Eli Lilly and Company (LLY): Price and Financial Metrics
Eli Lilly and Company (LLY)
Today's Latest Price: $119.64 USD
0.13 (-0.11%)
Updated Dec 6 12:00am
Add LLY to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 215 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
LLY Stock Summary
- With a market capitalization of $108,600,391,508, ELI LILLY & Co has a greater market value than 98.31% of US stocks.
- ELI LILLY & Co's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 94.5% of US listed stocks.
- Over the past twelve months, LLY has reported earnings growth of 161.78%, putting it ahead of 92.67% of US stocks in our set.
- If you're looking for stocks that are quantitatively similar to ELI LILLY & Co, a group of peers worth examining would be TXN, AZN, AMGN, PYPL, and SNY.
- LLY's SEC filings can be seen here. And to visit ELI LILLY & Co's official web site, go to www.lilly.com.
LLY Daily Price Range
LLY 52-Week Price Range
LLY Stock Price Chart More Charts
LLY Price/Volume Stats
| Current price | $119.64 |
| Prev. close | $119.77 |
| Day low | $119.58 |
| Day high | $120.70 |
| 50-day MA | $112.19 |
| 200-day MA | $115.49 |
| 52-week high | $132.13 |
| 52-week low | $101.36 |
| Volume | 2,462,800 |
| Avg. volume | 7,300,375 |
| Dividend yield | 2.16% |
| Market Cap | 114.87B |
Eli Lilly and Company (LLY) Company Bio
Eli Lilly discovers, develops, manufactures, and sells pharmaceutical products worldwide. It operates in two segments, Human Pharmaceutical Products and Animal Health products. The company was founded in 1876 and is based in Indianapolis, Indiana.
Top Stories View All
Best & Worst Performing Stock Industries for December 6, 2019
Best & Worst Performing Small Cap Stocks for December 6, 2019
Best & Worst Performing Mid Cap Stocks for December 6, 2019
Best & Worst Performing Large Cap Stocks for December 6, 2019
Best & Worst Performing Mega Cap Stocks for December 6, 2019
View All Top Stories
Loading social stream, please wait...